Cittadini A.Calviello G.HUI-MIN SUWeylandt K.2020-06-302020-06-3020132314-6133https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885677752&doi=10.1155%2f2013%2f905986&partnerID=40&md5=b26fb3615ecd71bbf877584cb79658efhttps://scholars.lib.ntu.edu.tw/handle/123456789/507128[SDGs]SDG2[SDGs]SDG3antineoplastic agent; docosahexaenoic acid; icosapentaenoic acid; omega 3 fatty acid; phospholipid; protein p53; reactive oxygen metabolite; triacylglycerol; adjuvant therapy; angiogenesis; antiarrhythmic activity; antiinflammatory activity; antineoplastic activity; apoptosis; autophagy; bladder cancer; cancer chemotherapy; cell proliferation; chronic kidney disease; colitis; degenerative disease; diet supplementation; diet therapy; dietary intake; disease activity; editorial; fibrinolysis; human; inflammatory disease; neoplasm; nonhuman; oxidative stress; pathogenesis; prostate cancer; protein expressioneditorial10.1155/2013/9059862-s2.0-84885677752